Literature DB >> 22598484

Phospholipid scramblase expression in the pregnant mouse uterus in LPS-induced preterm delivery.

Kelley C McLean1, Karen H Oppenheimer, Leigh M Sweet, Mark Phillippe.   

Abstract

Phospholipid scramblases (PLSCR), stimulated by proinflammatory cytokines, are thought to mediate the loss of lipid asymmetry in cell membranes, allowing for specific reactions in the coagulation cascade. The PLSCR may therefore provide a link between inflammation, coagulation, and, because thrombin is a uterotonic, preterm birth (PTB). To explore the relationship between PLSCR expression and inflammation-related PTB, we utilized reverse transcriptase-polymerase chain reaction and Western blot studies to quantify messenger RNA (mRNA) and protein expression for the 4 PLSCR homologues (PLSCR 1-4). Uteri from day 15 pregnant mice were harvested at several time points after intrauterine lipopolysaccharide (LPS) injection (or normal saline, for controls). Expression of mRNA in all 4 Plscr isoforms was demonstrated. Lipopolysaccharide treatment resulted in increased expression of PLSCR-1 and a decrease in Plscr4 mRNA, thereby demonstrating modulation of PLSCR-1 and PLSCR-4 in LPS-induced PTB. Additionally, protein expression was confirmed for all except PLSCR-4, with increased expression of PLSCR-1 after LPS treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22598484      PMCID: PMC4051404          DOI: 10.1177/1933719112446078

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  25 in total

1.  Identification of three new members of the phospholipid scramblase gene family.

Authors:  T Wiedmer; Q Zhou; D Y Kwoh; P J Sims
Journal:  Biochim Biophys Acta       Date:  2000-07-31

2.  Coagulation biomarkers in critically ill patients.

Authors:  Marcel Levi; Marcus Schultz; Tom van der Poll
Journal:  Crit Care Clin       Date:  2011-04       Impact factor: 3.598

3.  The role of thrombin in preterm parturition.

Authors:  M A Elovitz; J Baron; M Phillippe
Journal:  Am J Obstet Gynecol       Date:  2001-11       Impact factor: 8.661

4.  Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes.

Authors:  M T Gervasi; T Chaiworapongsa; N Naccasha; S Blackwell; B H Yoon; E Maymon; R Romero
Journal:  Am J Obstet Gynecol       Date:  2001-11       Impact factor: 8.661

5.  Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes.

Authors:  B H Yoon; R Romero; J B Moon; S S Shim; M Kim; G Kim; J K Jun
Journal:  Am J Obstet Gynecol       Date:  2001-11       Impact factor: 8.661

6.  Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes.

Authors:  T Rosen; E Kuczynski; L M O'Neill; E F Funai; C J Lockwood
Journal:  J Matern Fetal Med       Date:  2001-10

Review 7.  Unraveling the mysteries of phospholipid scrambling.

Authors:  P J Sims; T Wiedmer
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

8.  Thrombin-stimulated uterine contractions in the pregnant and nonpregnant rat.

Authors:  M Phillippe; M Elovitz; T Saunders
Journal:  J Soc Gynecol Investig       Date:  2001 Sep-Oct

9.  Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery.

Authors:  Fabio Ghezzi; Massimo Franchi; Luigi Raio; Edoardo Di Naro; Giuseppina Bossi; Gian Vico Melzi D'Eril; Pierfrancesco Bolis
Journal:  Am J Obstet Gynecol       Date:  2002-02       Impact factor: 8.661

10.  Effects of thrombin on myometrial contractions in vitro and in vivo.

Authors:  M A Elovitz; T Saunders; J Ascher-Landsberg; M Phillippe
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

View more
  1 in total

1.  Attenuation of endothelial phosphatidylserine exposure decreases ischemia-reperfusion induced changes in microvascular permeability.

Authors:  Aaron Strumwasser; Aditi Bhargava; Gregory P Victorino
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.